|
|
Volumn 57, Issue 3, 2006, Pages 309-316
|
|
A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
7 ETHYL 10 HYDROXYCAMPTOTHECIN BETA GLUCURONIDE;
7-ETHYL-10-HYDROXYCAMPTOTHECIN;
7-ETHYL-10-HYDROXYCAMPTOTHECIN BETA-GLUCURONIDE;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CHRYSIN;
DRUG DERIVATIVE;
FLAVONOID;
GLUCURONIC ACID;
GLUCURONOSYLTRANSFERASE;
PHENOL GLUCURONOSYLTRANSFERASE;
AREA UNDER THE CURVE;
ARTICLE;
BIOSYNTHESIS;
CELL STRAIN CACO 2;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
DIARRHEA;
DRUG ADMINISTRATION;
DRUG EFFECT;
ENZYME INDUCTION;
FEMALE;
GENETICS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METABOLISM;
METASTASIS;
MIDDLE AGED;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PILOT STUDY;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
CACO-2 CELLS;
CAMPTOTHECIN;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
COLORECTAL NEOPLASMS;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
ENZYME INDUCTION;
FEMALE;
FLAVONOIDS;
GLUCURONATES;
GLUCURONOSYLTRANSFERASE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEUTROPENIA;
PILOT PROJECTS;
|
|
EID: 33644838663
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-005-0053-0 Document Type: Article |
|
Times cited : (46)
|
|
References (0)
|
